Xiao Yao, Dong Shuai, Pan Chunyu, Guo Huiling, Tang Lili, Zhang Xizhe, Wang Fei
Early Intervention Unit, Department of Psychiatry, Affiliated Nanjing Brain Hospital, Nanjing Medical University, Nanjing 210029, China.
Functional Brain Imaging Institute of Nanjing Medical University, Nanjing 210029, China.
Psychoradiology. 2024 Nov 5;4:kkae025. doi: 10.1093/psyrad/kkae025. eCollection 2024.
The prefrontal cortex (PFC) is a critical non-invasive brain stimulation (NIBS) target for treating depression. However, the alterations of brain activations post-intervention remain inconsistent and the clinical moderators that could improve symptomatic effectiveness are unclear. The study aim was to systematically review the effectiveness of NIBS on depressive symptoms targeting PFC in functional magnetic resonance imaging (fMRI) studies. In our study, we delivered a combined activation likelihood estimation (ALE) meta-analysis and meta-regression. Until November 2020, three databases (PubMed, Web of Science, EMBASE) were searched and 14 studies with a total sample size of 584 were included in the ALE meta-analysis; after NIBS, four clusters in left cerebrum revealed significant activation while two clusters in right cerebrum revealed significant deactivation ( < 0.001, cluster size >150 mm). Eleven studies were statistically reanalyzed for depressive symptoms pre-post active-NIBS and the pooled effect size was very large [( = 1.82, 95%CI (1.23, 2.40)]; significant moderators causing substantial heterogeneity (Chi squared = 75.25, < 0.01; = 87%) were detected through subgroup analysis and univariate meta-regression. Multivariate meta-regression was then conducted accordingly and the model suggested good fitness ( = 42.32, < 0.01). In all, NIBS targeting PFC balanced three core depressive-related neurocognitive networks (the salience network, the default mode network, and the central executive network); the striatum played a central role and might serve as a candidate treatment biomarker; gender difference, treatment-resistant condition, comorbidity, treatment duration, and localization all contributed to moderating depressive symptoms during NIBS. More high-quality, multi-center randomized controlled trails delivering personalized NIBS are needed for clinical practice in the future.
前额叶皮质(PFC)是治疗抑郁症的关键非侵入性脑刺激(NIBS)靶点。然而,干预后脑激活的变化仍不一致,且尚不清楚哪些临床调节因素可提高症状改善效果。本研究旨在系统评价功能磁共振成像(fMRI)研究中,NIBS针对PFC治疗抑郁症状的有效性。在我们的研究中,我们进行了联合激活可能性估计(ALE)荟萃分析和荟萃回归。截至2020年11月,检索了三个数据库(PubMed、Web of Science、EMBASE),14项研究共584例样本纳入ALE荟萃分析;NIBS治疗后,左侧大脑四个簇显示显著激活,而右侧大脑两个簇显示显著失活(P<0.001,簇大小>150 mm)。对11项研究进行了主动NIBS前后抑郁症状的统计学重新分析,合并效应量非常大[Hedges' g = 1.82,95%CI(1.23,2.40)];通过亚组分析和单变量荟萃回归检测到导致显著异质性的显著调节因素(卡方 = 75.25,P<0.01;I² = 87%)。随后进行了多变量荟萃回归,模型显示拟合良好(χ² = 42.32,P<0.01)。总体而言,针对PFC的NIBS平衡了三个与抑郁相关的核心神经认知网络(突显网络、默认模式网络和中央执行网络);纹状体起核心作用,可能作为候选治疗生物标志物;性别差异、难治性情况、共病、治疗持续时间和定位均有助于调节NIBS期间的抑郁症状。未来临床实践需要更多高质量、多中心的随机对照试验来提供个性化的NIBS。